BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2003
View Archived Issues
Phase II findings for onercept in psoriasis and psoriatic arthritis
Read More
Peregrine presents antibodies targeting phosphatidylserine
Read More
Applied Molecular Evolution to optimize Lilly protein therapeutic candidates
Read More
Gilead and Bukwang clevudine licensing agreement terminated
Read More
Curis collaboration focusing on Hedgehog signaling pathway
Read More
Lorus selects lead antisense compound to target thioredoxin
Read More
Inflazyme completes acquisition of GlycoDesign
Read More
Y-700 found to inhibit uric acid formation in healthy adult volunteers
Read More
SCV-07 stimulates Th1 immune response in TB animal model
Read More
Analgesic effects reported for gabapentin in chronic radiculopathy
Read More
SMP-114 has good safety profile in healthy volunteers
Read More
Durable clinical response found for alefacept plus methotrexate in severe rheumatoid arthritis
Read More
Clinical benefits of a human monoclonal antibody against IL-15 in active rheumatoid arthritis
Read More
Three series of CCR3 antagonists with utility in asthma therapy claimed by Roche
Read More
New GABA-C receptor antagonists and their use as cognition-enhancing agents
Read More
Antitumor epothilones identified by Kosan scientists
Read More
Pharmacia (Pfizer) team identifies novel pyrazine-based CRF1 antagonists
Read More
Apoptosis inducers prepared and tested at the Burnham Institute
Read More
Scientists at Fujisawa and Daiso present novel apo B secretion inhibitors
Read More
New factor Xa inhibitors and their use covered by Warner-Lambert patent
Read More
Idec and Biogen to merge
Read More
Enbrel recommended by FDA panel to treat ankylosing spondylitis
Read More
Savient chosen as new corporate name for Bio-Technology General
Read More
Pilot study of Probuphine initiated for treatment of opiate addiction
Read More
MLN-2201 enters phase I testing
Read More
CPMP hands down positive opinion for survival claim for MabCampath
Read More
European Commission grants marketing authorization for Aldurazyme in Europe
Read More
FDA clears IND for dextofisopam for IBS
Read More